TNSN08536A1 - Quinolinone derivatives and their pharmaceutical compositions - Google Patents
Quinolinone derivatives and their pharmaceutical compositionsInfo
- Publication number
- TNSN08536A1 TNSN08536A1 TNP2008000536A TNSN08536A TNSN08536A1 TN SN08536 A1 TNSN08536 A1 TN SN08536A1 TN P2008000536 A TNP2008000536 A TN P2008000536A TN SN08536 A TNSN08536 A TN SN08536A TN SN08536 A1 TNSN08536 A1 TN SN08536A1
- Authority
- TN
- Tunisia
- Prior art keywords
- pharmaceutical compositions
- quinolinone derivatives
- compounds
- quinolinone
- derivatives
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical class C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 102100039705 Beta-2 adrenergic receptor Human genes 0.000 abstract 1
- 101710152983 Beta-2 adrenergic receptor Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 150000003839 salts Chemical group 0.000 abstract 1
- 239000012453 solvate Chemical group 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Compounds of formula (I) in salt or solvate form. wherein W. Rx, Ry, R1, R2, R3, R4, R5, R6 and R7 and A have the meanings, as indicated in the specification, are useful for treating diseases mediated by the β2 - adrenoreceptor. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0613158A GB0613158D0 (en) | 2006-06-30 | 2006-06-30 | Organic compounds |
GB0613159A GB0613159D0 (en) | 2006-06-30 | 2006-06-30 | Organic Compounds |
EP06117129A EP1878722A1 (en) | 2006-07-13 | 2006-07-13 | Quinolinone derivatives and their pharmaceutical compositions |
PCT/EP2007/056632 WO2008000839A1 (en) | 2006-06-30 | 2007-07-02 | Quinolinone derivatives and their pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN08536A1 true TNSN08536A1 (en) | 2010-04-14 |
Family
ID=90104634
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNP2008000536A TNSN08536A1 (en) | 2006-06-30 | 2008-12-26 | Quinolinone derivatives and their pharmaceutical compositions |
Country Status (1)
Country | Link |
---|---|
TN (1) | TNSN08536A1 (en) |
-
2008
- 2008-12-26 TN TNP2008000536A patent/TNSN08536A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TN2010000167A1 (en) | Organic compounds | |
MX2010006421A (en) | Organic compounds. | |
MX2014012695A (en) | Isoindolone derivatives. | |
MX2009010059A (en) | Quinoline derivatives for the treatment of inflammatory diseases. | |
TW200745066A (en) | Novel PTP1B inhibitors | |
ZA201000079B (en) | Organic compounds | |
GB0305152D0 (en) | Organic compounds | |
MX2009004715A (en) | Heterocyclic compounds as antiinflammatory agents. | |
MX2010003155A (en) | Cyclopropyl aryl amide derivatives and uses thereof. | |
GEP20146125B (en) | Aminopyrimidines as syk inhibitors | |
TW200628154A (en) | Organic compounds | |
TW200519106A (en) | Organic compounds | |
TW200833675A (en) | Nicotinamide derivatives | |
BRPI0409198A (en) | quinolin-2-one derivatives for the treatment of airway diseases | |
TW200726753A (en) | 2,4-diamino-pyrimidines as aurora inhibitors | |
TW200637863A (en) | Organic compounds | |
MY149512A (en) | Pyrazolylaminopyridine derivatives useful as kinase inhibitors | |
MX2010009022A (en) | 16 alpha, 17 alpa-acetal glucocorticosteroidal derivatives and their use. | |
TW200635921A (en) | Organic compounds | |
TW200745084A (en) | Novel compounds | |
TW200630366A (en) | Organic compounds | |
MX2012013274A (en) | Novel pyrimidine derivatives. | |
MX2007007720A (en) | Pyrrolinidium derivatives as m3 muscarinic receptors. | |
MX2009006010A (en) | Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases. | |
CY1113733T1 (en) | KINOLINONINE PRODUCERS AND THEIR PHARMACEUTICAL COMPOSITIONS |